See the Complete Picture.
Published loading...Updated

Kári says Amgen used trickery to get rid of him

Summary by Vísir
Kári Stefánsson, founder and outgoing CEO of Icelandic Genetics, says the parent company Amgen's approach to his retirement was marked by cronyism. He says a rumor that he intended to stand in the way of a full merger between Amgen and Icelandic Genetics was the main reason for his abrupt departure.
DisclaimerThis story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.

Bias Distribution

  • There is no tracked Bias information for the sources covering this story.
Factuality

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

Vísir broke the news in on Monday, May 5, 2025.
Sources are mostly out of (0)